The journal article, 'how do we forecast tomorrows' transfusion: non-transfusional hemotherapy', a retrospective review between 2000 and 2010 was performed.The review analyzed 2,730 procedures performed in 317 patients.During that period, renal diseases represented the 62 % of the patients treated followed by hematological (16 %) and neurological (9 %) conditions.Adverse effects were noted in 3% of the procedures, mostly related to mild citrate-induced symptoms (34 % of them) and mild hemodynamic changes (31 %).Patient information and outcomes, as well as whether medical intervention was necessary, were not provided in the article, therefore this report is being filed as a summary of events.The collection sets are not available for return for evaluation.
|
Lot number and expiry are not available at this time.Article citation: lozano, m.And cid, j.2023.How do we forecast tomorrows' transfusion: non-transfusional hemotherapy.Transfusion clinique et biologique., https://doi.Org/10.1016/j.Tracli.2023.01.007 investigation is in process.A follow up report will be provided.
|